 |
Welcome to |
|
BEAVERTON, Ore., April 22 /PRNewswire/ -- Epitope, Inc. (Nasdaq: EPTO) today announced that William D. Block has been appointed Vice President of Sales and Marketing, effective May 17, 1999. Mr. Block was hired following a national search for an experienced sales and marketing executive to replace Edward V. Collom, Jr., who resigned in March 1999 for health reasons. Mr. Block most recently served as Director of Institutional Sales for McKesson APS, a division of McKesson Corporation. Previously, he held a variety of other sales and management positions with companies in the medical field including: Allegiance Healthcare Corporation, Baxter Healthcare Corporation and Biotronics Enterprises, Inc. John W. Morgan, Epitope's president and chief executive officer, commented, "We are pleased to find someone with Bill's professionalism and broad medical sales experience. The growing complexity of Epitope's sales to direct customers, laboratories, distributors and partners requires a seasoned executive with Bill's expertise and leadership skills. His sales experience within the managed care sector, group purchasing organizations and the federal government will be invaluable in assisting our growth in these important markets. Therefore, we expect Bill to play a substantive role in increasing Epitope's revenues." Epitope, Inc. is an Oregon-based corporation that develops and markets medical devices and diagnostic products. Its focus is on products that use oral fluid in the detection of HIV infection, with emphasis in the life insurance and public health markets, drugs of abuse and other analytes. Statements in this press release about future sales levels or other future events or performance are forward-looking statements. The company's actual results could be significantly different. Factors that could affect results include the extent of future use of oral fluid testing with OraSure in the insurance industry or other key markets; loss or impairment of sources of capital; ability of the company to develop product distribution channels; ability of the company to develop new products; development of competing products; changes in international, federal or state law or regulations; uncertainties related to customers' and suppliers' ability to achieve year 2000 compliance; and loss of key personnel. Although forward-looking statements help to provide complete information about the company, readers should keep in mind that forward-looking statements are much less reliable than historical information. Source: EPITOPE Inc. Content of this page is copyright and reprinted here for educational and historical information. |
||
